188 related articles for article (PubMed ID: 37264815)
21. Recent advancements in optical biosensors for cancer detection.
Kaur B; Kumar S; Kaushik BK
Biosens Bioelectron; 2022 Feb; 197():113805. PubMed ID: 34801795
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
Liu C; Yang Y; Wu Y
AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer.
Sun M; Song J; Zhou Z; Zhu R; Jin H; Ji Y; Lu Q; Ju H
Dis Markers; 2016; 2016():3823121. PubMed ID: 26880855
[TBL] [Abstract][Full Text] [Related]
24. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in biosensor devices for HER-2 cancer biomarker detection.
Chupradit S; Jasim SA; Bokov D; Mahmoud MZ; Roomi AB; Hachem K; Rudiansyah M; Suksatan W; Bidares R
Anal Methods; 2022 Mar; 14(13):1301-1310. PubMed ID: 35318477
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the somatic mutations between circulating tumor DNA and tissue DNA in Chinese patients with non-small cell lung cancer.
Zhang M; Feng Y; Qu C; Meng M; Li W; Ye M; Li S; Li S; Ma Y; Wu N; Jia S
Int J Biol Markers; 2022 Dec; 37(4):386-394. PubMed ID: 35791673
[TBL] [Abstract][Full Text] [Related]
27. Optical Biosensor Based on Graphene and Its Derivatives for Detecting Biomolecules.
Ji G; Tian J; Xing F; Feng Y
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142748
[TBL] [Abstract][Full Text] [Related]
28. Electrochemical Biosensors for Circulating Tumor DNA Detection.
Wang K; Peng Z; Lin X; Nian W; Zheng X; Wu J
Biosensors (Basel); 2022 Aug; 12(8):. PubMed ID: 36005048
[TBL] [Abstract][Full Text] [Related]
29. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
30. Development of a QCM-based biosensor for the detection of non-small cell lung cancer biomarkers in liquid biopsies.
Lino C; Barrias S; Chaves R; Adega F; Fernandes JR; Martins-Lopes P
Talanta; 2023 Aug; 260():124624. PubMed ID: 37187027
[TBL] [Abstract][Full Text] [Related]
31. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
32. [Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE and ProGRP for lung cancers of different pathological types].
Gao J; Zhang L; Peng K; Sun H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):886-891. PubMed ID: 35790439
[TBL] [Abstract][Full Text] [Related]
33. Genotyping of common EGFR mutations in lung cancer patients by electrochemical biosensor.
Weng XH; Xu XW; Wang CL; Lin WW; Liu AL; Chen W; Lin XH
J Pharm Biomed Anal; 2018 Feb; 150():176-182. PubMed ID: 29245087
[TBL] [Abstract][Full Text] [Related]
34. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
[TBL] [Abstract][Full Text] [Related]
35. Cancer and Disease Diagnosis - Biosensor as Potential Diagnostic Tool for Biomarker Detection.
Chaudhry GE; Akim AM; Safdar N; Yasmin A; Begum S; Sung YY; Muhammad TST
J Adv Pharm Technol Res; 2022; 13(4):243-247. PubMed ID: 36568055
[TBL] [Abstract][Full Text] [Related]
36. Properties and Applications of Graphene and Its Derivatives in Biosensors for Cancer Detection: A Comprehensive Review.
Pourmadadi M; Soleimani Dinani H; Saeidi Tabar F; Khassi K; Janfaza S; Tasnim N; Hoorfar M
Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624570
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
38. Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing.
Chen KZ; Lou F; Yang F; Zhang JB; Ye H; Chen W; Guan T; Zhao MY; Su XX; Shi R; Jones L; Huang XF; Chen SY; Wang J
Sci Rep; 2016 Aug; 6():31985. PubMed ID: 27555497
[TBL] [Abstract][Full Text] [Related]
39. Advances in electrochemical-optical dual-mode biosensors for detection of environmental pathogens.
Hsu CY; Saleh RO; Pallathadka H; Kumar A; Mansouri S; Bhupathi P; Jasim Ali SH; Al-Mashhadani ZI; Alzubaidi LH; Hizam MM
Anal Methods; 2024 Feb; 16(9):1306-1322. PubMed ID: 38344759
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
